These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12895341)
21. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146 [TBL] [Abstract][Full Text] [Related]
22. p53 protein expression as prognostic factor in human pancreatic cancer. Sato Y; Nio Y; Song MM; Sumi S; Hirahara N; Minari Y; Tamura K Anticancer Res; 1997; 17(4A):2779-88. PubMed ID: 9252715 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer. Dang CX; Han Y; Qin ZY; Wang YJ Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290 [TBL] [Abstract][Full Text] [Related]
24. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Hermanova M; Trna J; Nenutil R; Dite P; Kala Z Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777 [TBL] [Abstract][Full Text] [Related]
25. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126 [TBL] [Abstract][Full Text] [Related]
26. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
27. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters. Ohtsubo K; Watanabe H; Yamaguchi Y; Hu YX; Motoo Y; Okai T; Sawabu N J Gastroenterol; 2003; 38(7):663-71. PubMed ID: 12898359 [TBL] [Abstract][Full Text] [Related]
28. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. Wang X; Zhang J; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas. Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815 [TBL] [Abstract][Full Text] [Related]
30. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations. Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407 [TBL] [Abstract][Full Text] [Related]
31. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153 [TBL] [Abstract][Full Text] [Related]
32. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas]. Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795 [TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954 [TBL] [Abstract][Full Text] [Related]
34. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer]. Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380 [TBL] [Abstract][Full Text] [Related]
35. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. Wang SN; Chung SC; Tsai KB; Chai CY; Chang WT; Kuo KK; Chen JS; Lee KT Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721 [TBL] [Abstract][Full Text] [Related]
36. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance]. Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047 [TBL] [Abstract][Full Text] [Related]
37. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations. Tomaszewska R; Nowak K; Stachura J Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116 [TBL] [Abstract][Full Text] [Related]
38. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas. Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199 [TBL] [Abstract][Full Text] [Related]
39. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Awadallah NS; Shroyer KR; Langer DA; Torkko KC; Chen YK; Bentz JS; Papkoff J; Liu W; Nash SR; Shah RJ Pancreas; 2008 Mar; 36(2):200-6. PubMed ID: 18376314 [TBL] [Abstract][Full Text] [Related]
40. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer. Li YJ; Meng YX; Ji XR Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]